Table 2.
Outcome | LDR | HDR | P value |
Local control at 2 years | |||
IB | 63% | 61% | 0.35 |
IIA | 86% | 90% | 0.68 |
IIB | 86% | 88% | 0.83 |
IIIA | 66% | 60% | 0.56 |
IIIB | 77% | 40% | 0.005 |
Disease-free survival at 2 years | |||
IB | 64% | 61% | 0.50 |
IIA | 81% | 69% | 0.18 |
IIB | 81% | 80% | 0.54 |
IIIA | 62% | 33% | 0.82 |
IIIB | 71% | 30% | 0.001 |
Overall survival at 2 years | |||
IB | 94% | 93% | 0.92 |
IIA | 98% | 68% | 0.21 |
IIB | 89% | 88% | 0.60 |
IIIB | 88% | 82% | 0.34 |
HDR, high-dose rate brachytherapy; LDR, low-dose rate brachytherapy.